| Noriko Okada, | |
|
325 Sharon Park Dr. #523, Menlo Park, CA 94025 | |
| (650) 736-9535 | |
| Not Available |
| Full Name | Noriko Okada |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 325 Sharon Park Dr. #523, Menlo Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265732739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 45243 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Noriko Okada, 325 Sharon Park Dr # 523, Menlo Park, CA 94025-6805 Ph: () - | Noriko Okada, 325 Sharon Park Dr. #523, Menlo Park, CA 94025 Ph: (650) 736-9535 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.
Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in vascular reconstructions by mechanically sealing areas of leakage. The US Food and Drug Administration (FDA) recently granted approval of the Premarket Approval Application (PMA) for ETHICON™ OMNEX™ Surgical Sealant.
The World Health Organization (WHO) says there had been no reports of bird flu in the Chinese village where a 10-year-old girl has fallen ill with bird flu, and they are concerned that poultry outbreaks may be going undetected or unreported in China.
The HIV Medicine Association applauds the Obama administration's release of a National HIV/AIDS Strategy that signals a strengthened national commitment to real and sustained success in the battle against HIV/AIDS. As clinicians and researchers on the frontline of this pandemic, we welcome this new comprehensive roadmap and look forward to working with diverse stakeholders at all levels of government and within the private sector to implement it.
More than half a century after researchers identified a promising way to treat diabetes based on blocking the breakdown of insulin in the body, a research team led by a scientist at the Mayo Clinic campus in Florida have developed potent molecules that can do just that.
› Verified 8 days ago
Merika Starr, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 871 Santa Cruz Ave, Menlo Park, CA 94025 Phone: 650-618-6310 | |
Sageda Mahmoud-thirucote, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Willow Rd, Menlo Park, CA 94025 Phone: 650-326-8400 Fax: 650-323-2609 | |
Maryam Arabpour Dahooei, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 871 Santa Cruz Ave, Menlo Park, CA 94025 Phone: 650-618-6310 | |
Tian Hu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Sharon Park Dr, Menlo Park, CA 94025 Phone: 650-854-4636 | |
Laura Diesh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 643 Santa Cruz Ave, Menlo Park, CA 94025 Phone: 650-321-1530 | |
Janell Sanford, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 871 Santa Cruz Ave, Menlo Park, CA 94025 Phone: 650-618-6310 | |
Sung Jae Back Durham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 871 Santa Cruz Ave, Menlo Park, CA 94025 Phone: 650-618-6300 Fax: 650-618-6311 |